| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Multiple Sclerosis | 65 | 2019 | 262 | 5.240 |
Why?
|
| Interferon-beta | 24 | 2019 | 125 | 3.250 |
Why?
|
| Adjuvants, Immunologic | 15 | 2016 | 167 | 1.580 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 13 | 2018 | 54 | 1.540 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 23 | 2002 | 57 | 1.070 |
Why?
|
| Interferon beta-1b | 18 | 2018 | 39 | 1.030 |
Why?
|
| Myasthenia Gravis | 18 | 2008 | 83 | 1.020 |
Why?
|
| T-Lymphocytes | 29 | 2009 | 1195 | 0.820 |
Why?
|
| Sympathetic Nervous System | 8 | 1999 | 104 | 0.710 |
Why?
|
| T-Lymphocytes, Regulatory | 16 | 2001 | 295 | 0.630 |
Why?
|
| Receptors, Fc | 3 | 2011 | 33 | 0.600 |
Why?
|
| Demyelinating Diseases | 14 | 2011 | 68 | 0.570 |
Why?
|
| Immunoglobulin G | 17 | 2007 | 456 | 0.560 |
Why?
|
| Adrenocorticotropic Hormone | 3 | 2012 | 131 | 0.530 |
Why?
|
| Interferon-gamma | 8 | 1999 | 444 | 0.500 |
Why?
|
| Adrenergic beta-Agonists | 4 | 2008 | 72 | 0.480 |
Why?
|
| Melanocortins | 1 | 2012 | 4 | 0.450 |
Why?
|
| Antibodies, Neutralizing | 4 | 2018 | 112 | 0.450 |
Why?
|
| Lymphocytes | 19 | 1995 | 464 | 0.430 |
Why?
|
| Receptors, Adrenergic, beta | 9 | 1995 | 72 | 0.430 |
Why?
|
| Lymphocyte Activation | 21 | 2009 | 728 | 0.430 |
Why?
|
| Monocytes | 7 | 2009 | 214 | 0.410 |
Why?
|
| Botulism | 1 | 2011 | 6 | 0.400 |
Why?
|
| Bacterial Vaccines | 1 | 2011 | 41 | 0.400 |
Why?
|
| Receptors, Cholinergic | 10 | 1993 | 76 | 0.390 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2011 | 49 | 0.380 |
Why?
|
| Antigen-Presenting Cells | 1 | 2011 | 139 | 0.380 |
Why?
|
| Immune System | 3 | 1999 | 93 | 0.370 |
Why?
|
| Receptors, Cell Surface | 2 | 2009 | 286 | 0.370 |
Why?
|
| Humans | 122 | 2019 | 86643 | 0.360 |
Why?
|
| Terbutaline | 3 | 2008 | 16 | 0.350 |
Why?
|
| Autoimmune Diseases | 12 | 1996 | 241 | 0.340 |
Why?
|
| Myelin Basic Protein | 8 | 2002 | 49 | 0.340 |
Why?
|
| Glatiramer Acetate | 6 | 2016 | 14 | 0.320 |
Why?
|
| Immunologic Factors | 3 | 2018 | 170 | 0.320 |
Why?
|
| T-Lymphocyte Subsets | 4 | 1999 | 272 | 0.320 |
Why?
|
| Adult | 61 | 2018 | 25648 | 0.310 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2011 | 683 | 0.310 |
Why?
|
| Animals | 78 | 2011 | 26582 | 0.300 |
Why?
|
| Middle Aged | 50 | 2019 | 25028 | 0.290 |
Why?
|
| Immunity, Cellular | 11 | 1990 | 177 | 0.280 |
Why?
|
| Recurrence | 8 | 2015 | 1139 | 0.280 |
Why?
|
| Peptides | 5 | 2011 | 639 | 0.270 |
Why?
|
| Autoantibodies | 8 | 2008 | 267 | 0.270 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 6 | 1991 | 95 | 0.270 |
Why?
|
| Clinical Trials as Topic | 6 | 2012 | 1169 | 0.270 |
Why?
|
| Interferon beta-1a | 6 | 2016 | 18 | 0.260 |
Why?
|
| Antigens, Surface | 8 | 1987 | 101 | 0.260 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2011 | 557 | 0.260 |
Why?
|
| Female | 62 | 2018 | 44532 | 0.260 |
Why?
|
| Oligodendroglia | 6 | 2011 | 123 | 0.250 |
Why?
|
| Antibodies, Monoclonal | 15 | 2001 | 1376 | 0.240 |
Why?
|
| Concanavalin A | 14 | 1995 | 52 | 0.240 |
Why?
|
| Immunosuppressive Agents | 8 | 2009 | 977 | 0.230 |
Why?
|
| Male | 51 | 2018 | 40965 | 0.230 |
Why?
|
| Rats | 32 | 2002 | 3990 | 0.220 |
Why?
|
| Tumor Cells, Cultured | 4 | 1997 | 1041 | 0.210 |
Why?
|
| Peripheral Nervous System Diseases | 4 | 2006 | 85 | 0.210 |
Why?
|
| T-Lymphocytes, Cytotoxic | 4 | 1988 | 315 | 0.210 |
Why?
|
| Cells, Cultured | 20 | 2011 | 2818 | 0.210 |
Why?
|
| Etretinate | 1 | 2001 | 4 | 0.200 |
Why?
|
| Neuroblastoma | 4 | 1989 | 374 | 0.200 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 1 | 2001 | 8 | 0.200 |
Why?
|
| HLA-DRB1 Chains | 2 | 2018 | 28 | 0.200 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2009 | 425 | 0.190 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 3 | 1996 | 132 | 0.190 |
Why?
|
| Double-Blind Method | 5 | 2015 | 1823 | 0.190 |
Why?
|
| Brain | 11 | 2009 | 2216 | 0.190 |
Why?
|
| Antibody Formation | 9 | 1998 | 171 | 0.190 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 1999 | 5 | 0.180 |
Why?
|
| Ganglia, Sympathetic | 2 | 1990 | 8 | 0.180 |
Why?
|
| Cytokines | 4 | 1999 | 776 | 0.180 |
Why?
|
| Neuroprotection | 1 | 2019 | 7 | 0.180 |
Why?
|
| Isoproterenol | 5 | 1995 | 59 | 0.180 |
Why?
|
| Nerve Tissue Proteins | 5 | 2011 | 503 | 0.180 |
Why?
|
| Recombinant Proteins | 6 | 2008 | 1014 | 0.180 |
Why?
|
| Spinal Cord | 8 | 2002 | 249 | 0.170 |
Why?
|
| Mitoxantrone | 3 | 2011 | 68 | 0.170 |
Why?
|
| Spodoptera | 3 | 2011 | 32 | 0.170 |
Why?
|
| Neuroglia | 7 | 1989 | 104 | 0.170 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2015 | 3362 | 0.170 |
Why?
|
| Interleukin-2 | 4 | 1999 | 249 | 0.170 |
Why?
|
| Mice | 26 | 2011 | 11352 | 0.160 |
Why?
|
| Muscles | 4 | 1982 | 194 | 0.160 |
Why?
|
| Interferons | 1 | 1998 | 133 | 0.160 |
Why?
|
| Beta-Globulins | 1 | 1997 | 4 | 0.150 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 1997 | 10 | 0.150 |
Why?
|
| Aging | 7 | 1983 | 691 | 0.150 |
Why?
|
| Interleukin-4 | 2 | 1999 | 127 | 0.150 |
Why?
|
| Tretinoin | 1 | 1998 | 126 | 0.150 |
Why?
|
| Blood Cells | 2 | 1995 | 33 | 0.150 |
Why?
|
| Antigens | 5 | 2007 | 228 | 0.150 |
Why?
|
| Central Nervous System | 3 | 2012 | 151 | 0.150 |
Why?
|
| Serum Albumin | 6 | 2007 | 130 | 0.150 |
Why?
|
| Polyneuropathies | 3 | 1987 | 27 | 0.140 |
Why?
|
| CD8 Antigens | 3 | 1991 | 82 | 0.140 |
Why?
|
| International Cooperation | 1 | 2016 | 127 | 0.140 |
Why?
|
| Nerve Growth Factors | 4 | 1989 | 63 | 0.140 |
Why?
|
| Trigeminal Neuralgia | 1 | 1995 | 6 | 0.130 |
Why?
|
| Genetic Vectors | 2 | 2011 | 439 | 0.130 |
Why?
|
| Sympathectomy, Chemical | 3 | 1994 | 6 | 0.130 |
Why?
|
| Misoprostol | 1 | 1995 | 15 | 0.130 |
Why?
|
| Cell Line | 11 | 2011 | 2468 | 0.130 |
Why?
|
| Amyotrophic Lateral Sclerosis | 4 | 1982 | 182 | 0.130 |
Why?
|
| Adolescent | 20 | 2011 | 8981 | 0.130 |
Why?
|
| Antibody-Producing Cells | 2 | 1993 | 16 | 0.130 |
Why?
|
| Receptors, Immunologic | 3 | 2009 | 135 | 0.130 |
Why?
|
| Cerebral Cortex | 3 | 1990 | 584 | 0.130 |
Why?
|
| Thyroid Hormones | 1 | 1997 | 321 | 0.130 |
Why?
|
| Fluorescent Antibody Technique | 4 | 2009 | 316 | 0.120 |
Why?
|
| Immunotherapy | 2 | 2002 | 629 | 0.120 |
Why?
|
| Mice, Inbred BALB C | 5 | 2011 | 1047 | 0.120 |
Why?
|
| Cell Separation | 4 | 2009 | 196 | 0.120 |
Why?
|
| Receptors, IgG | 2 | 2007 | 52 | 0.120 |
Why?
|
| Disability Evaluation | 4 | 2015 | 136 | 0.120 |
Why?
|
| Cell Differentiation | 2 | 2011 | 1458 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 1 | 1997 | 937 | 0.120 |
Why?
|
| Ligands | 3 | 2012 | 433 | 0.120 |
Why?
|
| Flow Cytometry | 5 | 2009 | 679 | 0.120 |
Why?
|
| Rats, Inbred Lew | 10 | 2002 | 186 | 0.120 |
Why?
|
| Leukocytes, Mononuclear | 2 | 1996 | 196 | 0.120 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2014 | 80 | 0.110 |
Why?
|
| Disease Models, Animal | 10 | 2006 | 2232 | 0.110 |
Why?
|
| Vitamin D | 1 | 2015 | 261 | 0.110 |
Why?
|
| Receptors, Neurotransmitter | 1 | 1993 | 25 | 0.110 |
Why?
|
| Receptors, Melanocortin | 1 | 2012 | 2 | 0.110 |
Why?
|
| Renin-Angiotensin System | 1 | 2014 | 133 | 0.110 |
Why?
|
| Antigens, CD | 2 | 1992 | 458 | 0.110 |
Why?
|
| Skin | 2 | 2001 | 554 | 0.110 |
Why?
|
| Disease Progression | 5 | 2016 | 1531 | 0.110 |
Why?
|
| Immunologic Capping | 4 | 1982 | 14 | 0.110 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2014 | 231 | 0.110 |
Why?
|
| Depression | 1 | 2016 | 473 | 0.110 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 1920 | 0.110 |
Why?
|
| Endopeptidases | 2 | 1982 | 116 | 0.110 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2012 | 73 | 0.110 |
Why?
|
| Receptors, Muscarinic | 1 | 1992 | 49 | 0.110 |
Why?
|
| Central Nervous System Diseases | 2 | 2006 | 52 | 0.100 |
Why?
|
| Spleen | 8 | 1999 | 430 | 0.100 |
Why?
|
| Immunoglobulin M | 5 | 2002 | 154 | 0.100 |
Why?
|
| Young Adult | 7 | 2016 | 5976 | 0.100 |
Why?
|
| Fingolimod Hydrochloride | 1 | 2011 | 29 | 0.100 |
Why?
|
| Narcolepsy | 2 | 1990 | 9 | 0.100 |
Why?
|
| Antitoxins | 1 | 2011 | 2 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2016 | 1961 | 0.100 |
Why?
|
| Time Factors | 9 | 2019 | 5210 | 0.100 |
Why?
|
| Baculoviridae | 1 | 2011 | 34 | 0.100 |
Why?
|
| Spasms, Infantile | 1 | 2011 | 30 | 0.100 |
Why?
|
| Vaccines, Synthetic | 1 | 2011 | 55 | 0.100 |
Why?
|
| HLA Antigens | 4 | 1987 | 232 | 0.100 |
Why?
|
| Vaccines, Subunit | 1 | 2011 | 55 | 0.100 |
Why?
|
| Polyradiculoneuropathy | 2 | 1987 | 8 | 0.100 |
Why?
|
| Subacute Sclerosing Panencephalitis | 2 | 1981 | 16 | 0.100 |
Why?
|
| Drug Therapy, Combination | 3 | 2014 | 894 | 0.100 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 1991 | 17 | 0.100 |
Why?
|
| Disease Susceptibility | 1 | 2011 | 193 | 0.100 |
Why?
|
| Antibodies, Bacterial | 1 | 2011 | 95 | 0.100 |
Why?
|
| Huntington Disease | 2 | 1981 | 37 | 0.100 |
Why?
|
| Cerebrospinal Fluid | 3 | 1985 | 32 | 0.100 |
Why?
|
| Drug Resistance | 1 | 2011 | 256 | 0.100 |
Why?
|
| Culture Media | 2 | 1990 | 147 | 0.090 |
Why?
|
| Nerve Tissue | 2 | 1988 | 8 | 0.090 |
Why?
|
| Brain Tissue Transplantation | 1 | 1990 | 5 | 0.090 |
Why?
|
| In Vitro Techniques | 6 | 1999 | 989 | 0.090 |
Why?
|
| Bucladesine | 1 | 1989 | 13 | 0.090 |
Why?
|
| B7-2 Antigen | 1 | 2009 | 40 | 0.090 |
Why?
|
| Patient Safety | 1 | 2012 | 212 | 0.090 |
Why?
|
| Antigens, Ly | 1 | 1990 | 37 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2012 | 339 | 0.090 |
Why?
|
| B7-1 Antigen | 1 | 2009 | 75 | 0.090 |
Why?
|
| Proto-Oncogenes | 1 | 1989 | 61 | 0.090 |
Why?
|
| Antigen-Antibody Complex | 4 | 1982 | 87 | 0.090 |
Why?
|
| Lymphocyte Depletion | 1 | 1990 | 97 | 0.090 |
Why?
|
| Nervous System Diseases | 2 | 1991 | 151 | 0.090 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2011 | 165 | 0.090 |
Why?
|
| Galvanic Skin Response | 1 | 1989 | 12 | 0.090 |
Why?
|
| Rabies Vaccines | 3 | 1987 | 7 | 0.090 |
Why?
|
| Age Factors | 7 | 2015 | 1851 | 0.090 |
Why?
|
| Neurotransmitter Agents | 1 | 1990 | 106 | 0.090 |
Why?
|
| Diabetic Neuropathies | 1 | 1989 | 40 | 0.090 |
Why?
|
| Pheochromocytoma | 1 | 1989 | 49 | 0.090 |
Why?
|
| Pilot Projects | 2 | 2008 | 839 | 0.090 |
Why?
|
| Pyridostigmine Bromide | 1 | 2008 | 11 | 0.080 |
Why?
|
| Aged | 22 | 2008 | 18415 | 0.080 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2008 | 45 | 0.080 |
Why?
|
| Inflammation | 4 | 2008 | 920 | 0.080 |
Why?
|
| Myelitis, Transverse | 1 | 2008 | 10 | 0.080 |
Why?
|
| Salivary Glands, Minor | 1 | 2008 | 9 | 0.080 |
Why?
|
| Submandibular Gland Diseases | 1 | 2008 | 9 | 0.080 |
Why?
|
| Placebos | 1 | 2008 | 218 | 0.080 |
Why?
|
| Neuromyelitis Optica | 1 | 2008 | 22 | 0.080 |
Why?
|
| Serum Albumin, Bovine | 6 | 2002 | 45 | 0.080 |
Why?
|
| Guinea Pigs | 8 | 1998 | 171 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2018 | 2357 | 0.080 |
Why?
|
| Receptors, Nicotinic | 3 | 1993 | 129 | 0.080 |
Why?
|
| Antineoplastic Agents | 2 | 2002 | 2360 | 0.080 |
Why?
|
| Cross-Over Studies | 1 | 2008 | 399 | 0.080 |
Why?
|
| Myelin Sheath | 6 | 1989 | 84 | 0.080 |
Why?
|
| Membrane Glycoproteins | 1 | 2009 | 428 | 0.080 |
Why?
|
| Papaverine | 2 | 1984 | 5 | 0.070 |
Why?
|
| Neuropsychological Tests | 2 | 2001 | 502 | 0.070 |
Why?
|
| Hydrocortisone | 3 | 1974 | 298 | 0.070 |
Why?
|
| Histocompatibility Antigens | 3 | 1992 | 35 | 0.070 |
Why?
|
| Cyclosporins | 1 | 1986 | 59 | 0.070 |
Why?
|
| Graft Rejection | 2 | 1990 | 1065 | 0.070 |
Why?
|
| Glioma | 3 | 1984 | 285 | 0.070 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1989 | 645 | 0.070 |
Why?
|
| Signal Transduction | 2 | 2012 | 3241 | 0.070 |
Why?
|
| Sheep | 9 | 1991 | 239 | 0.070 |
Why?
|
| Treatment Outcome | 6 | 2013 | 7993 | 0.070 |
Why?
|
| Diphtheria Toxin | 3 | 1974 | 20 | 0.070 |
Why?
|
| Mitogens | 4 | 1980 | 64 | 0.070 |
Why?
|
| Immunoglobulins | 7 | 1993 | 148 | 0.070 |
Why?
|
| Peripheral Nerves | 3 | 1974 | 36 | 0.070 |
Why?
|
| Gadolinium | 2 | 2011 | 103 | 0.070 |
Why?
|
| Animals, Newborn | 3 | 2011 | 510 | 0.070 |
Why?
|
| Gene Expression | 1 | 1989 | 1284 | 0.070 |
Why?
|
| gamma-Globulins | 4 | 1965 | 16 | 0.060 |
Why?
|
| Antibodies, Viral | 3 | 1974 | 293 | 0.060 |
Why?
|
| Follow-Up Studies | 4 | 2015 | 3640 | 0.060 |
Why?
|
| Binding Sites, Antibody | 2 | 2001 | 49 | 0.060 |
Why?
|
| Macrophages | 3 | 1985 | 554 | 0.060 |
Why?
|
| Lymph Nodes | 3 | 1999 | 533 | 0.060 |
Why?
|
| Thymectomy | 4 | 1990 | 31 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2009 | 1578 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 1989 | 1981 | 0.060 |
Why?
|
| Leukocyte Count | 4 | 1984 | 220 | 0.060 |
Why?
|
| Azathioprine | 2 | 1982 | 125 | 0.060 |
Why?
|
| Research | 4 | 1965 | 253 | 0.060 |
Why?
|
| Hypergammaglobulinemia | 1 | 1983 | 8 | 0.060 |
Why?
|
| Serum Globulins | 2 | 1981 | 12 | 0.060 |
Why?
|
| Substantia Gelatinosa | 1 | 1982 | 4 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 2271 | 0.060 |
Why?
|
| Guanosine Diphosphate | 1 | 1982 | 19 | 0.060 |
Why?
|
| Mice, SCID | 2 | 1993 | 252 | 0.060 |
Why?
|
| Guanine Nucleotides | 1 | 1982 | 14 | 0.050 |
Why?
|
| Picornaviridae Infections | 1 | 1982 | 7 | 0.050 |
Why?
|
| Heparin | 2 | 1974 | 175 | 0.050 |
Why?
|
| Immunization | 4 | 1989 | 158 | 0.050 |
Why?
|
| S-Nitrosothiols | 1 | 2002 | 5 | 0.050 |
Why?
|
| Antibody Specificity | 5 | 2002 | 129 | 0.050 |
Why?
|
| Blood | 1 | 1982 | 69 | 0.050 |
Why?
|
| Receptors, Complement | 1 | 1982 | 46 | 0.050 |
Why?
|
| Kainic Acid | 1 | 1981 | 22 | 0.050 |
Why?
|
| Immunization, Passive | 2 | 1985 | 71 | 0.050 |
Why?
|
| Child | 8 | 2011 | 6927 | 0.050 |
Why?
|
| Rosette Formation | 5 | 1991 | 34 | 0.050 |
Why?
|
| Drug Synergism | 2 | 2001 | 303 | 0.050 |
Why?
|
| Neoplasms, Experimental | 5 | 1984 | 269 | 0.050 |
Why?
|
| Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase | 1 | 2001 | 7 | 0.050 |
Why?
|
| Immunoelectrophoresis | 4 | 1974 | 19 | 0.050 |
Why?
|
| Rabbits | 6 | 1982 | 636 | 0.050 |
Why?
|
| Pyrrolidines | 1 | 1981 | 58 | 0.050 |
Why?
|
| Antibody Affinity | 1 | 2001 | 38 | 0.050 |
Why?
|
| Pindolol | 2 | 1991 | 6 | 0.050 |
Why?
|
| Cysteine | 1 | 2002 | 135 | 0.050 |
Why?
|
| Molecular Weight | 1 | 2001 | 332 | 0.050 |
Why?
|
| Dimerization | 1 | 2001 | 143 | 0.050 |
Why?
|
| Mice, Inbred Strains | 3 | 1990 | 307 | 0.050 |
Why?
|
| Glycosylation | 1 | 2001 | 129 | 0.050 |
Why?
|
| Cell Division | 3 | 1998 | 696 | 0.050 |
Why?
|
| Immunodiffusion | 3 | 1965 | 28 | 0.050 |
Why?
|
| Pituitary Hormones | 2 | 1991 | 7 | 0.050 |
Why?
|
| Respirovirus | 2 | 1977 | 3 | 0.050 |
Why?
|
| Acute Disease | 3 | 1996 | 826 | 0.050 |
Why?
|
| Quality of Life | 2 | 2001 | 1585 | 0.050 |
Why?
|
| Interleukin-12 | 1 | 2001 | 108 | 0.050 |
Why?
|
| Triglycerides | 1 | 2001 | 232 | 0.050 |
Why?
|
| Autonomic Agents | 1 | 1999 | 1 | 0.050 |
Why?
|
| Acetylcholine | 2 | 1980 | 176 | 0.050 |
Why?
|
| Protein Engineering | 1 | 2001 | 140 | 0.050 |
Why?
|
| Up-Regulation | 2 | 1994 | 712 | 0.050 |
Why?
|
| Thymus Gland | 5 | 1978 | 195 | 0.040 |
Why?
|
| Open Reading Frames | 1 | 2019 | 117 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2001 | 782 | 0.040 |
Why?
|
| Pokeweed Mitogens | 5 | 1986 | 10 | 0.040 |
Why?
|
| Herpes Simplex | 2 | 1978 | 202 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 736 | 0.040 |
Why?
|
| Neural Conduction | 4 | 1974 | 69 | 0.040 |
Why?
|
| Genotype | 2 | 2015 | 1851 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1999 | 100 | 0.040 |
Why?
|
| Cerebral Ventricles | 2 | 1990 | 76 | 0.040 |
Why?
|
| RNA, Long Noncoding | 1 | 2019 | 102 | 0.040 |
Why?
|
| Reflex | 2 | 1989 | 79 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1999 | 102 | 0.040 |
Why?
|
| Lymphotoxin-alpha | 1 | 1998 | 44 | 0.040 |
Why?
|
| Meta-Analysis as Topic | 2 | 2011 | 87 | 0.040 |
Why?
|
| Prednisone | 2 | 1995 | 258 | 0.040 |
Why?
|
| Optic Neuritis | 2 | 1974 | 10 | 0.040 |
Why?
|
| Evoked Potentials | 2 | 1996 | 190 | 0.040 |
Why?
|
| Electrophoresis, Agar Gel | 3 | 1982 | 49 | 0.040 |
Why?
|
| Polymers | 1 | 1999 | 202 | 0.040 |
Why?
|
| Genome-Wide Association Study | 2 | 2018 | 1621 | 0.040 |
Why?
|
| Lipocalins | 1 | 1997 | 35 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 1998 | 149 | 0.040 |
Why?
|
| Rats, Inbred WF | 2 | 1989 | 8 | 0.040 |
Why?
|
| Potassium | 2 | 1988 | 281 | 0.040 |
Why?
|
| Tacrolimus | 1 | 1998 | 373 | 0.040 |
Why?
|
| Lymphocyte Transfusion | 2 | 1993 | 41 | 0.040 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 1988 | 213 | 0.040 |
Why?
|
| Submandibular Gland | 2 | 1975 | 16 | 0.040 |
Why?
|
| Binding, Competitive | 2 | 1990 | 145 | 0.040 |
Why?
|
| Rats, Inbred Strains | 2 | 1990 | 312 | 0.040 |
Why?
|
| Transplantation, Homologous | 2 | 1990 | 996 | 0.040 |
Why?
|
| Paraneoplastic Syndromes | 2 | 1987 | 16 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2018 | 4213 | 0.040 |
Why?
|
| Killer Cells, Natural | 1 | 1998 | 267 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 1997 | 646 | 0.030 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2015 | 7 | 0.030 |
Why?
|
| B-Lymphocytes | 6 | 1984 | 724 | 0.030 |
Why?
|
| Membrane Potentials | 4 | 1990 | 435 | 0.030 |
Why?
|
| Polylysine | 1 | 1975 | 33 | 0.030 |
Why?
|
| Gene Deletion | 1 | 1997 | 329 | 0.030 |
Why?
|
| Electric Stimulation | 3 | 1990 | 347 | 0.030 |
Why?
|
| Prostaglandins E, Synthetic | 1 | 1995 | 3 | 0.030 |
Why?
|
| Antidepressive Agents | 1 | 2016 | 106 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2002 | 1036 | 0.030 |
Why?
|
| Mumps virus | 1 | 1974 | 3 | 0.030 |
Why?
|
| Cell Membrane | 3 | 2011 | 666 | 0.030 |
Why?
|
| Poliovirus | 1 | 1974 | 23 | 0.030 |
Why?
|
| Transcriptome | 1 | 2019 | 580 | 0.030 |
Why?
|
| Image Enhancement | 1 | 1999 | 563 | 0.030 |
Why?
|
| Cattle | 6 | 1982 | 376 | 0.030 |
Why?
|
| Measles virus | 1 | 1974 | 14 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 1997 | 301 | 0.030 |
Why?
|
| Diphtheria Toxoid | 2 | 1964 | 3 | 0.030 |
Why?
|
| Creatine Kinase | 1 | 1974 | 52 | 0.030 |
Why?
|
| Protamines | 1 | 1974 | 8 | 0.030 |
Why?
|
| Reference Values | 1 | 1995 | 674 | 0.030 |
Why?
|
| Inulin | 1 | 1974 | 17 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2016 | 487 | 0.030 |
Why?
|
| Oxidopamine | 1 | 1994 | 8 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 1998 | 559 | 0.030 |
Why?
|
| Suicide | 1 | 2016 | 139 | 0.030 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 1994 | 19 | 0.030 |
Why?
|
| Contrast Media | 1 | 1999 | 1078 | 0.030 |
Why?
|
| Neurons | 1 | 1982 | 1546 | 0.030 |
Why?
|
| Antibodies | 3 | 1979 | 350 | 0.030 |
Why?
|
| Base Sequence | 1 | 1997 | 2330 | 0.030 |
Why?
|
| Kinetics | 4 | 1988 | 1513 | 0.030 |
Why?
|
| Fibroblasts | 2 | 1975 | 729 | 0.030 |
Why?
|
| Sodium | 1 | 1974 | 341 | 0.030 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2012 | 42 | 0.030 |
Why?
|
| Peptide Fragments | 2 | 2007 | 460 | 0.030 |
Why?
|
| Autoimmunity | 1 | 1994 | 160 | 0.030 |
Why?
|
| Aspartic Acid Endopeptidases | 2 | 1982 | 66 | 0.030 |
Why?
|
| Contraceptives, Oral | 2 | 1969 | 46 | 0.030 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1992 | 66 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 1997 | 3030 | 0.030 |
Why?
|
| N-Methylscopolamine | 1 | 1992 | 2 | 0.030 |
Why?
|
| Scopolamine Derivatives | 1 | 1992 | 4 | 0.030 |
Why?
|
| CD4 Antigens | 1 | 1992 | 83 | 0.030 |
Why?
|
| Drug Administration Schedule | 2 | 2008 | 916 | 0.030 |
Why?
|
| Sciatic Nerve | 4 | 1974 | 33 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 1019 | 0.030 |
Why?
|
| CD2 Antigens | 2 | 1991 | 22 | 0.030 |
Why?
|
| Biopsy | 2 | 2008 | 1163 | 0.030 |
Why?
|
| Clone Cells | 3 | 1980 | 213 | 0.030 |
Why?
|
| Cerebrospinal Fluid Proteins | 2 | 1982 | 9 | 0.030 |
Why?
|
| Isoelectric Focusing | 2 | 1982 | 39 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 1992 | 70 | 0.030 |
Why?
|
| Culture Techniques | 5 | 1985 | 91 | 0.030 |
Why?
|
| Incidence | 1 | 2016 | 1577 | 0.030 |
Why?
|
| Oligodendrocyte Transcription Factor 2 | 1 | 2011 | 5 | 0.030 |
Why?
|
| Cell Count | 2 | 1982 | 195 | 0.020 |
Why?
|
| Staining and Labeling | 2 | 1982 | 165 | 0.020 |
Why?
|
| Nerve Regeneration | 1 | 2011 | 32 | 0.020 |
Why?
|
| CD28 Antigens | 1 | 1991 | 88 | 0.020 |
Why?
|
| Polyradiculopathy | 1 | 1971 | 6 | 0.020 |
Why?
|
| Cyclic AMP | 2 | 1990 | 273 | 0.020 |
Why?
|
| Neurons, Afferent | 1 | 1991 | 79 | 0.020 |
Why?
|
| Infant | 2 | 2011 | 3046 | 0.020 |
Why?
|
| CD3 Complex | 2 | 1996 | 135 | 0.020 |
Why?
|
| Freund's Adjuvant | 2 | 1974 | 26 | 0.020 |
Why?
|
| Virus Diseases | 3 | 1982 | 97 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 1994 | 313 | 0.020 |
Why?
|
| Observer Variation | 1 | 2012 | 602 | 0.020 |
Why?
|
| Receptors, Adrenergic | 1 | 1990 | 15 | 0.020 |
Why?
|
| Biological Factors | 1 | 1990 | 18 | 0.020 |
Why?
|
| Comorbidity | 1 | 1994 | 943 | 0.020 |
Why?
|
| H-2 Antigens | 1 | 1990 | 58 | 0.020 |
Why?
|
| Acetylcholinesterase | 1 | 1989 | 47 | 0.020 |
Why?
|
| Propranolol | 1 | 1989 | 45 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2011 | 678 | 0.020 |
Why?
|
| Psychometrics | 1 | 2011 | 327 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1989 | 245 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2011 | 677 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 1990 | 153 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 1989 | 256 | 0.020 |
Why?
|
| Sweat Glands | 1 | 1989 | 6 | 0.020 |
Why?
|
| Genes, ras | 1 | 1989 | 96 | 0.020 |
Why?
|
| Isoantigens | 2 | 1986 | 66 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 1989 | 120 | 0.020 |
Why?
|
| Phorbol Esters | 1 | 1988 | 22 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2015 | 8489 | 0.020 |
Why?
|
| Colforsin | 1 | 1988 | 74 | 0.020 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1989 | 80 | 0.020 |
Why?
|
| Microscopy, Electron | 2 | 1980 | 503 | 0.020 |
Why?
|
| Progesterone | 1 | 1969 | 110 | 0.020 |
Why?
|
| Histocompatibility Testing | 2 | 1982 | 154 | 0.020 |
Why?
|
| Sjogren's Syndrome | 1 | 2008 | 30 | 0.020 |
Why?
|
| Hydroxydopamines | 1 | 1988 | 7 | 0.020 |
Why?
|
| Prognosis | 2 | 2015 | 3679 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1989 | 302 | 0.020 |
Why?
|
| HLA-DR Antigens | 1 | 1987 | 61 | 0.020 |
Why?
|
| Macrophage-1 Antigen | 1 | 1987 | 17 | 0.020 |
Why?
|
| Mice, Inbred CBA | 1 | 1987 | 52 | 0.020 |
Why?
|
| Estrogens | 1 | 1969 | 200 | 0.020 |
Why?
|
| Binding Sites | 2 | 1982 | 1098 | 0.020 |
Why?
|
| HLA-DQ Antigens | 1 | 1987 | 52 | 0.020 |
Why?
|
| Hypersensitivity, Delayed | 2 | 1969 | 25 | 0.020 |
Why?
|
| Erythrocytes | 3 | 1982 | 255 | 0.020 |
Why?
|
| Hemagglutination | 2 | 1979 | 7 | 0.020 |
Why?
|
| U937 Cells | 1 | 2007 | 32 | 0.020 |
Why?
|
| Typhoid-Paratyphoid Vaccines | 2 | 1982 | 5 | 0.020 |
Why?
|
| Necrosis | 1 | 1987 | 204 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2011 | 536 | 0.020 |
Why?
|
| Neuritis, Autoimmune, Experimental | 1 | 1987 | 7 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2011 | 709 | 0.020 |
Why?
|
| Monoclonal Gammopathy of Undetermined Significance | 1 | 1987 | 8 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1987 | 158 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2011 | 376 | 0.020 |
Why?
|
| Epilepsy | 1 | 2011 | 397 | 0.020 |
Why?
|
| Growth Substances | 1 | 1986 | 80 | 0.020 |
Why?
|
| Skin Transplantation | 1 | 1987 | 172 | 0.020 |
Why?
|
| Potassium Channels | 1 | 1989 | 340 | 0.020 |
Why?
|
| Immune Sera | 2 | 1980 | 52 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 696 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 1621 | 0.020 |
Why?
|
| Phenotype | 2 | 1988 | 2378 | 0.020 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 1985 | 44 | 0.020 |
Why?
|
| Neoplasm Transplantation | 2 | 1984 | 391 | 0.020 |
Why?
|
| Massive Hepatic Necrosis | 1 | 1964 | 1 | 0.020 |
Why?
|
| Carbon Tetrachloride Poisoning | 1 | 1964 | 3 | 0.020 |
Why?
|
| Pharmacology | 1 | 1964 | 11 | 0.020 |
Why?
|
| Blood Protein Electrophoresis | 1 | 1964 | 15 | 0.020 |
Why?
|
| Spinal Cord Neoplasms | 1 | 1985 | 48 | 0.020 |
Why?
|
| Antibodies, Neoplasm | 1 | 1985 | 84 | 0.020 |
Why?
|
| Salmonella typhi | 1 | 1964 | 7 | 0.020 |
Why?
|
| Radioimmunoassay | 2 | 1982 | 155 | 0.020 |
Why?
|
| Toxicology | 1 | 1964 | 16 | 0.020 |
Why?
|
| Hepatitis | 1 | 1964 | 35 | 0.020 |
Why?
|
| Neutralization Tests | 2 | 1974 | 77 | 0.020 |
Why?
|
| Astrocytes | 1 | 1985 | 139 | 0.020 |
Why?
|
| Neuromuscular Junction | 2 | 1976 | 80 | 0.020 |
Why?
|
| Transplantation Immunology | 1 | 1965 | 84 | 0.020 |
Why?
|
| Ovalbumin | 1 | 1964 | 109 | 0.020 |
Why?
|
| Mitomycins | 1 | 1984 | 13 | 0.020 |
Why?
|
| Mitomycin | 1 | 1984 | 29 | 0.020 |
Why?
|
| Carbon | 1 | 1964 | 80 | 0.020 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 1964 | 69 | 0.020 |
Why?
|
| Typhoid Fever | 1 | 1964 | 4 | 0.020 |
Why?
|
| Body Weight | 2 | 1975 | 459 | 0.020 |
Why?
|
| Prevalence | 1 | 2008 | 1239 | 0.020 |
Why?
|
| Models, Biological | 1 | 1991 | 1749 | 0.020 |
Why?
|
| Physiology | 1 | 1964 | 16 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 1989 | 1801 | 0.010 |
Why?
|
| Polysaccharides, Bacterial | 1 | 1964 | 31 | 0.010 |
Why?
|
| Streptococcus pneumoniae | 1 | 1964 | 48 | 0.010 |
Why?
|
| Hybrid Cells | 2 | 1980 | 72 | 0.010 |
Why?
|
| Lymphocyte Subsets | 2 | 1995 | 64 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 1988 | 1753 | 0.010 |
Why?
|
| Polysaccharides | 1 | 1964 | 89 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2011 | 1565 | 0.010 |
Why?
|
| Sural Nerve | 1 | 1983 | 19 | 0.010 |
Why?
|
| Vaccination | 1 | 1965 | 254 | 0.010 |
Why?
|
| Mice, Neurologic Mutants | 1 | 1982 | 18 | 0.010 |
Why?
|
| Axons | 1 | 1984 | 174 | 0.010 |
Why?
|
| Immunoglobulin Light Chains | 1 | 1983 | 86 | 0.010 |
Why?
|
| Pepstatins | 1 | 1982 | 3 | 0.010 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 1983 | 131 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1982 | 130 | 0.010 |
Why?
|
| Interferon-alpha | 1 | 2003 | 233 | 0.010 |
Why?
|
| Antilymphocyte Serum | 1 | 1982 | 71 | 0.010 |
Why?
|
| Phagocytes | 1 | 1982 | 10 | 0.010 |
Why?
|
| Muscular Atrophy | 1 | 1982 | 41 | 0.010 |
Why?
|
| Immunologic Techniques | 1 | 1982 | 27 | 0.010 |
Why?
|
| Nitroso Compounds | 1 | 2002 | 12 | 0.010 |
Why?
|
| Plasmapheresis | 1 | 1982 | 26 | 0.010 |
Why?
|
| Oxidoreductases | 1 | 1982 | 112 | 0.010 |
Why?
|
| Neuritis | 2 | 1974 | 8 | 0.010 |
Why?
|
| Remission, Spontaneous | 1 | 2002 | 53 | 0.010 |
Why?
|
| Genes, MHC Class II | 1 | 1982 | 30 | 0.010 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1982 | 47 | 0.010 |
Why?
|
| Receptors, Kainic Acid | 1 | 1981 | 13 | 0.010 |
Why?
|
| Ketoglutaric Acids | 1 | 1981 | 12 | 0.010 |
Why?
|
| Levamisole | 2 | 1979 | 5 | 0.010 |
Why?
|
| Contact Inhibition | 1 | 1981 | 3 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 1985 | 532 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2003 | 227 | 0.010 |
Why?
|
| Glycoproteins | 1 | 1983 | 234 | 0.010 |
Why?
|
| Forecasting | 1 | 2002 | 304 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 1982 | 299 | 0.010 |
Why?
|
| Immunity | 1 | 1962 | 136 | 0.010 |
Why?
|
| Glutamates | 1 | 1981 | 89 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2003 | 297 | 0.010 |
Why?
|
| Mice, Inbred A | 2 | 1984 | 23 | 0.010 |
Why?
|
| Interleukin-1 | 2 | 1991 | 71 | 0.010 |
Why?
|
| Epitopes | 1 | 1982 | 255 | 0.010 |
Why?
|
| Myelin Proteins | 1 | 1981 | 13 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 2426 | 0.010 |
Why?
|
| Densitometry | 1 | 1981 | 29 | 0.010 |
Why?
|
| 2',3'-Cyclic-Nucleotide Phosphodiesterases | 1 | 1980 | 10 | 0.010 |
Why?
|
| Immune Complex Diseases | 1 | 1981 | 19 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 1981 | 152 | 0.010 |
Why?
|
| Isoelectric Point | 1 | 1980 | 16 | 0.010 |
Why?
|
| Myeloma Proteins | 1 | 1980 | 32 | 0.010 |
Why?
|
| Carbohydrates | 1 | 1980 | 47 | 0.010 |
Why?
|
| Motor Neurons | 1 | 1982 | 162 | 0.010 |
Why?
|
| Colchicine | 1 | 1980 | 23 | 0.010 |
Why?
|
| Neutrophils | 1 | 1982 | 307 | 0.010 |
Why?
|
| Solubility | 1 | 1980 | 177 | 0.010 |
Why?
|
| Agglutination | 1 | 1979 | 17 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 1988 | 806 | 0.010 |
Why?
|
| Parasympatholytics | 1 | 1979 | 18 | 0.010 |
Why?
|
| Carbachol | 1 | 1979 | 34 | 0.010 |
Why?
|
| Mycobacterium tuberculosis | 2 | 1974 | 186 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 1982 | 337 | 0.010 |
Why?
|
| Liver | 1 | 1964 | 1230 | 0.010 |
Why?
|
| Research Design | 1 | 2003 | 594 | 0.010 |
Why?
|
| Cobra Neurotoxin Proteins | 1 | 1979 | 1 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1979 | 23 | 0.010 |
Why?
|
| Cerebrovascular Disorders | 1 | 1980 | 143 | 0.010 |
Why?
|
| Protein Binding | 1 | 1983 | 1456 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2002 | 1686 | 0.010 |
Why?
|
| CD4-CD8 Ratio | 1 | 1998 | 18 | 0.010 |
Why?
|
| Motor Endplate | 2 | 1993 | 31 | 0.010 |
Why?
|
| Cell Cycle | 1 | 1980 | 502 | 0.010 |
Why?
|
| Amyloidosis | 1 | 1980 | 115 | 0.010 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 1977 | 7 | 0.010 |
Why?
|
| Hemagglutination Inhibition Tests | 2 | 1974 | 37 | 0.010 |
Why?
|
| Chick Embryo | 2 | 1975 | 229 | 0.010 |
Why?
|
| Immunoassay | 2 | 1975 | 92 | 0.010 |
Why?
|
| Lectins | 1 | 1978 | 84 | 0.010 |
Why?
|
| Methods | 2 | 1974 | 152 | 0.010 |
Why?
|
| Dogs | 2 | 1985 | 685 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2002 | 1673 | 0.010 |
Why?
|
| Maus Elberfeld virus | 1 | 1976 | 34 | 0.010 |
Why?
|
| Enterovirus | 1 | 1976 | 34 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1998 | 684 | 0.010 |
Why?
|
| Spinal Cord Diseases | 1 | 1976 | 29 | 0.010 |
Why?
|
| RNA | 1 | 1980 | 560 | 0.010 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 1976 | 74 | 0.010 |
Why?
|
| Electromyography | 2 | 1981 | 183 | 0.010 |
Why?
|
| Optic Nerve | 1 | 1976 | 35 | 0.010 |
Why?
|
| Kidney | 2 | 1974 | 1241 | 0.010 |
Why?
|
| Thymoma | 1 | 1976 | 30 | 0.010 |
Why?
|
| Graft vs Host Reaction | 1 | 1975 | 15 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 1995 | 29 | 0.010 |
Why?
|
| Orchitis | 1 | 1975 | 10 | 0.010 |
Why?
|
| Mitotic Index | 1 | 1975 | 20 | 0.010 |
Why?
|
| Thymus Neoplasms | 1 | 1976 | 41 | 0.010 |
Why?
|
| Eye | 1 | 1976 | 111 | 0.010 |
Why?
|
| Biomarkers | 1 | 2002 | 1718 | 0.010 |
Why?
|
| Sex Factors | 2 | 1976 | 1054 | 0.010 |
Why?
|
| Haplorhini | 1 | 1974 | 81 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 1980 | 763 | 0.010 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 1975 | 124 | 0.010 |
Why?
|
| Pregnancy | 1 | 1982 | 2894 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1995 | 152 | 0.010 |
Why?
|
| DNA | 1 | 1980 | 1294 | 0.010 |
Why?
|
| Myositis | 1 | 1974 | 17 | 0.010 |
Why?
|
| Muscular Dystrophies | 1 | 1974 | 54 | 0.010 |
Why?
|
| Sodium Isotopes | 1 | 1974 | 1 | 0.010 |
Why?
|
| Serum Albumin, Radio-Iodinated | 1 | 1974 | 6 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 1974 | 35 | 0.010 |
Why?
|
| Radioisotopes | 1 | 1974 | 45 | 0.010 |
Why?
|
| Water-Electrolyte Balance | 1 | 1974 | 66 | 0.010 |
Why?
|
| Species Specificity | 1 | 1975 | 678 | 0.010 |
Why?
|
| Extracellular Space | 1 | 1974 | 90 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 1974 | 119 | 0.010 |
Why?
|
| Organ Size | 1 | 1974 | 364 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1980 | 3612 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 1974 | 283 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1993 | 348 | 0.010 |
Why?
|
| Leukocyte Common Antigens | 1 | 1992 | 46 | 0.010 |
Why?
|
| Cell Survival | 2 | 1988 | 969 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 1974 | 459 | 0.010 |
Why?
|
| Alprostadil | 1 | 1991 | 25 | 0.010 |
Why?
|
| Blood Glucose | 1 | 1975 | 873 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1995 | 971 | 0.010 |
Why?
|
| Measles | 1 | 1971 | 15 | 0.010 |
Why?
|
| Dog Diseases | 1 | 1971 | 35 | 0.010 |
Why?
|
| Encephalomyelitis | 1 | 1970 | 6 | 0.010 |
Why?
|
| Mycoplasma Infections | 1 | 1970 | 8 | 0.010 |
Why?
|
| Chemotaxis | 1 | 1971 | 72 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1985 | 268 | 0.010 |
Why?
|
| Muscle Tonus | 1 | 1970 | 19 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1996 | 2705 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 1991 | 256 | 0.010 |
Why?
|
| Hemagglutination Tests | 1 | 1969 | 11 | 0.010 |
Why?
|
| Medroxyprogesterone | 1 | 1969 | 6 | 0.010 |
Why?
|
| Agglutination Tests | 1 | 1969 | 11 | 0.010 |
Why?
|
| Tissue Extracts | 1 | 1969 | 24 | 0.010 |
Why?
|
| Ethinyl Estradiol | 1 | 1969 | 16 | 0.010 |
Why?
|
| Hypersensitivity | 1 | 1970 | 154 | 0.010 |
Why?
|
| Second Messenger Systems | 1 | 1988 | 41 | 0.010 |
Why?
|
| Tetraethylammonium Compounds | 1 | 1988 | 14 | 0.010 |
Why?
|
| Cesium | 1 | 1988 | 25 | 0.010 |
Why?
|
| Electric Conductivity | 1 | 1988 | 144 | 0.010 |
Why?
|
| Tetraethylammonium | 1 | 1988 | 24 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1988 | 137 | 0.010 |
Why?
|
| Electrophoresis | 1 | 1988 | 55 | 0.010 |
Why?
|
| 4-Aminopyridine | 1 | 1988 | 32 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 1996 | 2501 | 0.010 |
Why?
|
| Aminopyridines | 1 | 1988 | 38 | 0.000 |
Why?
|
| Glucocorticoids | 1 | 1970 | 352 | 0.000 |
Why?
|
| Electrophysiology | 1 | 1988 | 401 | 0.000 |
Why?
|
| Coliphages | 2 | 1977 | 59 | 0.000 |
Why?
|
| Collodion | 1 | 1985 | 7 | 0.000 |
Why?
|
| Paper | 1 | 1985 | 10 | 0.000 |
Why?
|
| Ganglia, Spinal | 2 | 1977 | 72 | 0.000 |
Why?
|
| Biological Assay | 2 | 1977 | 78 | 0.000 |
Why?
|
| Dihydroalprenolol | 1 | 1984 | 1 | 0.000 |
Why?
|
| Lymphocyte Cooperation | 1 | 1983 | 4 | 0.000 |
Why?
|
| Antigens, T-Independent | 1 | 1982 | 4 | 0.000 |
Why?
|
| Immunoglobulin A | 1 | 1982 | 80 | 0.000 |
Why?
|
| Glia Maturation Factor | 1 | 1981 | 1 | 0.000 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1980 | 112 | 0.000 |
Why?
|
| Trypsin | 1 | 1980 | 95 | 0.000 |
Why?
|
| Genes, Dominant | 1 | 1980 | 117 | 0.000 |
Why?
|
| Chromosome Disorders | 1 | 1980 | 114 | 0.000 |
Why?
|
| Chromosome Aberrations | 1 | 1980 | 387 | 0.000 |
Why?
|
| Fishes | 1 | 1979 | 137 | 0.000 |
Why?
|
| Immune Adherence Reaction | 1 | 1975 | 4 | 0.000 |
Why?
|
| Multiple Myeloma | 1 | 1979 | 307 | 0.000 |
Why?
|
| Complement System Proteins | 1 | 1975 | 81 | 0.000 |
Why?
|
| Autopsy | 1 | 1975 | 116 | 0.000 |
Why?
|
| DNA Viruses | 1 | 1974 | 16 | 0.000 |
Why?
|
| Mediastinum | 1 | 1971 | 46 | 0.000 |
Why?
|
| Preoperative Care | 1 | 1971 | 397 | 0.000 |
Why?
|